13 March 2018
Authored and Edited by Sanam Habib; Hazel Ford, Ph.D.
As part of the maintenance of pending European patent applications, annual renewal fees are charged by the EPO. These fees are due at the end of the month containing the anniversary of the filing date. The first fee to be paid is the third year renewal fee, due at the end of the month containing the second anniversary of the filing date.
Since 2009, the EPO has not permitted renewal fees to be paid more than three months before the due date. Payments made earlier are not valid and will be refunded by the EPO, except when paid shortly before the permissible prepayment period. For Euro-PCT applications, it has therefore been common for the third year renewal fee payment window to open after the 31 month time limit for entering the European regional phase. This restriction is applied by the EPO to prevent Applicants from making multiple payments in advance thereby avoiding future increases in fees.
However, with effect from 1 April 2018, the payment window for the third year renewal fee is being extended. It will now be possible for Applicants to pay the third year renewal fee up to six months before it falls due. This change means that, in most cases, Applicants will now have the opportunity to pay the third year renewal fee at the same time they bring a PCT application into the regional phase in the EPO.
This change applies to any application for which the third year renewal fee is paid on or after 1 April 2018.
It is to be noted that the change only applies to the third year renewal fee, subsequent renewal fees may still only be validly paid within a three month window before they fall due.
Applicants should also note that they can still pay the third year renewal fee closer to the due date if they wish.
Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
INCONTESTABLE® Blog
April 19, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.